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S U M M A R Y
Background: Knowledge of nasal carriage is important in predicting staphylococcal infection, and no
information exists regarding the endemicity of Staphylococcus aureus in Haiti.
Methods: We performed a cross-sectional analysis of S. aureus nasal screening in an acute care, a
subacute rehabilitation, and a community setting, with a brief medical and epidemiological history. PCR-
positive S. aureus screening nasal cultures underwent molecular analysis for spa type, SCCmec type, and
virulence genes (Panton–Valentine leukocidin (PVL), toxic shock syndrome toxin (TSST), and arginine
catabolic mobile element (ACME)), and were evaluated for antibiotic susceptibility using commercial
tests.
Results: Overall carriage rates of 8.4% methicillin-susceptible S. aureus (MSSA) and 2.8% methicillin-
resistant S. aureus (MRSA) were identiﬁed, with a high rate of tetracycline resistance. TSST and PVL genes
were identiﬁed in MSSA. MRSA isolates contained no virulence markers. Unique MSSA phenotypes (i.e.,
linezolid-resistant, vancomycin-sensitive/daptomycin non-susceptible) were identiﬁed, as were two
PVL-positive ST152 MSSA colonization isolates, previously geographically limited to Africa.
Conclusions: We found a low S. aureus carriage rate with complete vancomycin susceptibility and high
tetracycline resistance, which has important public health implications with regard to treatment.
Additionally, the ﬁnding of PVL-positive MSSA isolates, including the expansion of a previously described
limited ‘divergent’ clone, ST152, warrants further evaluation.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
On January 12, 2010 a devastating magnitude 7.2 earthquake
destroyed Port-au-Prince, Haiti, leaving over 222 000 dead and
300 000 injured.1 Two million residents were displaced from
their homes; many found temporary shelter in unsanitary and* Corresponding author. Tel.: +1 732 776 2389; fax: +1 732 776 3795.
E-mail address: mrosenthal@meridianhealth.com (M.E. Rosenthal).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).potentially unsafe conditions, such as tent cities. Injuries were
treated at Hoˆpital Adventiste in Port-au-Prince, in addition to
many make-shift ﬁeld hospitals.2–4 Victims were transported from
the epicenter to Hoˆpital Sacre´ Coeur in Milot, some 138 km, or 7 h
ground travel over rough terrain. Hoˆpital Sacre´ Coeur quickly
became inundated with patients, and its maximum capacity was
surpassed, necessitating the use of temporary tents which
functioned as patient wards and pre- and postoperative patient
care units. It was hypothesized that, similar to the situation
following the devastating earthquake in 2008 in Wenchuanciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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wound cultures would be Staphylococcus aureus.5 It is accepted that
nasal carriage is an important risk factor for staphylococcal
infection, whether through endogenous acquisition (i.e., self-
inoculation) or nosocomial transmission via the hands or instru-
ments of the health-care delivery system.6,7 Knowledge of S. aureus
epidemiology is important for public health treatment and
prevention strategies when facing natural disasters, such as
earthquakes.
Minimal information is known regarding the endemicity of
both methicillin-susceptible and methicillin-resistant S. aureus
(MSSA and MRSA, respectively) in Haiti, especially in the post-
earthquake period. A review of the literature revealed only one
prior report regarding the clinical signiﬁcance of S. aureus in Haiti,
which concerned a neonatal HIV population with S. aureus
bacteremia.8
The purpose of this study was to determine the distribution of S.
aureus nasal carriage and self-reported or documented infections
in patients, visitors, and health-care workers at three unique
locations in post-earthquake northern Haiti: (1) currently hospi-
talized patients, caregivers/visitors, and health-care workers at an
acute care hospital, (2) patients, visitors, and health-care workers
at a subacute rehabilitation facility, and (3) patients, visitors, and
staff seeking care from a community dispensary (clinic). We sought
to describe the molecular epidemiology of nasal carriage isolates
based on genotyping of staphylococcal protein A (spa), staphylo-
coccal cassette chromosome mec (SCCmec), and putative virulence
factors, as well as to evaluate automated methicillin susceptibility
proﬁles to determine intrinsic carriage rates of MRSA.
2. Methods
This internally funded, institutional review board approved,
cross-sectional study utilizing microbiological and molecular
epidemiological methods took place in June 2012 in northern
Haiti, 75 nautical miles north of Port-au-Prince. Three locations
(hereafter identiﬁed as locations A, B, and C) were chosen. Location
A, an acute care 88-bed hospital at the time of the earthquake,
increased capacity to nearly 400 patients at the peak post-
earthquake. This hospital has operating rooms, an intensive care
unit, and a maternity ward, and was the main site for study
participation. Adult patients housed in 8–10-bed separate male
and female medical and surgical wards and a maternity ward were
approached. Overﬂow patients were housed along the hallway
corridors. Family members collected medication prescriptions at
the centralized hospital pharmacy (including intravenous sets and
syringes). Location B, a 30-bed long-term rehabilitation facility and
national referral center located 24 km from location A, includes a
multi-bed single room unit with a separate physical therapy and
rehabilitation area. Location C, a community dispensary/clinic,
serves the local community on a walk-in basis.
Using a Creole-speaking interpreter, patients, visitors, and
employees at the three locations were invited to participate in an
anonymous survey and submit to nasal screening for the
assessment of S. aureus risk and carriage. Informed consent was
implied by voluntary participation in this anonymous survey and
screening, after an introduction to the purpose, method, and design
of the study was provided verbally to each patient, visitor, and staff
member, at each location, and all questions had been answered.
Voluntary, non-remunerated participants were assigned anon-
ymized serial study numbers. A brief medical history was taken
and a questionnaire administered verbally to participants to collect
data on medical and surgical conditions, antibiotic usage history,
and place of residence during the 2010 earthquake, as well as
contact or care of earthquake victims. Translated responses wererecorded on-site by participating authors (MR, JS, LP, and AS) prior
to obtaining nasal cultures.
Cultures were obtained by inserting a commercial dual-tipped
culturette swab into bilateral anterior nares and rotating ﬁve times
in a clockwise direction prior to returning the swab to the transport
tube, which contained Stuart’s medium (BBL Culture Swabs;
Becton Dickinson). Numbered swabs were collected and placed in a
refrigerated unit in the hospital laboratory of location A within 4 h
of collection and were stored for up to 1 week. Swabs were
transported on ice to the Public Health Research Institute at
Rutgers University in Newark, New Jersey, USA by study personnel.
All swabs were then plated on non-selective Luria Broth (LB)
medium. Total bacterial DNA was isolated from overnight cultures
using a boiling lysis method.
Real-time PCR with molecular beacons speciﬁc for the
staphylococcal protein A (spa) gene was used to identify nasal
screens containing S. aureus.9,10 Bacterial isolates with positive spa
PCR for S. aureus were then plated on selective CHROMagar (BBL
media). Three mauve S. aureus colonies were picked from
CHROMagar and re-streaked on LB plates. DNA isolation was
accomplished using previously published methods.11 Genetic
characterization by sequencing the variable number tandem
repeats in the protein A gene (spa typing) with the use of
eGenomics software, as described previously, allowed for assign-
ment to clonal complexes (CCs).11,12 Both the US eGenomics-based
spa typing assignment and the European Ridom StaphType,
denoted by ‘t’, are reported.13,14 Any unassigned eGenomics or
Ridom sequences were submitted for spa type assignment (http://
tools.egenomics.com and http://spa.ridom.de/submission.shtml,
respectively). The detection of genes for the arginine catabolic
mobile element (ACME), Panton–Valentine leukocidin (PVL), and
staphylococcal toxic shock syndrome toxin (TSST) was done using
PCR-based techniques completed in triplicate.
Automated susceptibility determination for standard antibio-
tics (VITEK2; bioMe´rieux, Durham, NC, USA), or manual testing
using Etest strips for non-automated antibiotics (such as
daptomycin), was performed according to standard laboratory
procedures. Clindamycin susceptibility was conﬁrmed for induc-
ible resistance using the D test.15 The following antibiotics were
tested: penicillin, oxacillin, gentamicin, ciproﬂoxacin, erythromy-
cin, clindamycin, quinupristin–dalfopristin, linezolid, vancomycin,
tetracycline, tigecycline, rifampin, trimethoprim–sulfamethoxa-
zole, and daptomycin. Standard published Clinical and Laboratory
Standards Institute (CLSI) breakpoints were used for interpreta-
tion. As daptomycin breakpoints are not established, non-
susceptibility was deﬁned as a minimum inhibitory concentration
(MIC) 1.5.
2.1. Statistical methods
Continuous variables were summarized using the mean and
range, and categorical variables were summarized using the
frequency and percentage. Fisher’s exact test was used to compare
the proportions between groups. The two-sided p-value was
reported for each test, with p < 0.05 considered an indication of
statistical signiﬁcance.
3. Results
Of 150 persons approached at the three distinct locations,
143 agreed to participate; more than half of these persons were
female (62%, 89/143). One hundred six patients, visitors, and staff
from location A, 24 from location B, and 13 from location C,
completed the questionnaire and agreed to nasal swabs. Baseline
demographics are shown in Table 1. Birthdates were approximated
Table 1
Distribution of patients, visitors, and staff by location
Age, years,
range (mean)
Male (%) Medical
ward (%)
Surgical
ward (%)
Emergency
room tent (%)
Length of stay,
range (mean)
Location A: acute care hospital (n = 106)
Patients (n = 41) 18–95 (48.7) 36.6 63.4 31.7 4.9 0–84 (11.6) days
Visitors (n = 29) 19–75 (41.4) 24.1 79.3 6.9 13.8 NA
Staff (n = 36) 25–63 (35.4) 25 NA NA NA NA
Location B: subacute rehabilitation hospital (n = 24)
Patients (n = 15) 18–65 (42.9) 86.7 60 NA NA 1–30 (12.7) months
Visitors (n = 4) 27–50 (37.5) 100 NA NA NA NA
Staff (n = 5) 22–42 (33.2) 20 NA NA NA NA
Location C: community dispensary/clinic (n = 13)
Patients (n = 7) 27–80 (40.6) 28.6 57.1 NA NA NA
Visitors (n = 1) 31 0 NA NA NA NA
Staff (n = 5) 34–65 (48.4) 60 NA NA NA NA
NA, not applicable.
Table 2
Distributions of MSSA and MRSA
S. aureus MSSA MRSA
n No Yes No Yes No Yes
Location A
Patient 41 37 4 37 4 41 0
Visitor 29 27 2 27 2 29 0
Staff 36 29 7 32 4 36 3
Location B
Patient 15 13 2 14 1 14 1
Visitor 4 4 0 4 0 4 0
Staff 5 5 0 5 0 5 0
Location C
Patient 7 6 1 6 1 7 0
Visitor 1 1 0 1 0 1 0
Staff 5 5 0 5 0 5 0
Total 143 127 16 131 12 139 4
MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus.
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an exact date of birth.
Location A included 41 patients admitted for documented
infections such as known HIV (n = 2), oral abscess, axillary abscess,
pneumonia, conjunctivitis, puncture wound to the foot, and foot
ulcers (n = 1 each). Suspected infection presenting with fever
(n = 7) and/or cough (n = 3) accounted for an additional 10 patients.
Cardiovascular and pulmonary diagnoses included hypertension
and heart failure (n = 1 each) and dyspnea with or without asthma
(n = 1 and n = 2, respectively), as well as bilateral lower extremity
edema (n = 3). Gastrointestinal (GI) complaints, such as abdominal
pain (n = 2) and ascites, gastritis, GI malignancy, and nausea/
vomiting (n = 1 each) accounted for additional admissions.
Hyperglycemia and diabetic ketoacidosis accounted for two
admissions, and musculoskeletal admissions included back/
shoulder pain, knee swelling, and ankle swelling (n = 1 each), as
well as a motor vehicle trauma (n = 1). Antepartum patients with
pre-eclampsia, eclampsia, fetal death, and full-term labor
accounted for an additional ﬁve patients. Twenty-nine visitors/
caregivers and 36 employees agreed to participate.
Of the 41 patients, 17 were receiving antibiotic monotherapy or
combination therapy with the following agents: ampicillin,
amoxicillin, amoxicillin–clavulanate, azithromycin, ceftriaxone,
ciproﬂoxacin, clindamycin, co-trimoxazole, metronidazole, and
penicillin G. Visitors had been prescribed amoxicillin and
doxycycline, while staff reported past exposure to amoxicillin,
ciproﬂoxacin, erythromycin, and metronidazole, mostly for
reported diagnoses of urinary tract infection.
At location B, 15 patients, four visitors, and ﬁve employees
participated. Most admissions were for rehabilitation secondary to
spinal cord injury with paralysis (n = 9); others included patients
with gunshot wounds (n = 2) and stroke, pelvic fracture, and crush
injury (n = 1 each). Seven of 15 patients were receiving antibiotic
regimens, including amoxicillin, ampicillin, ciproﬂoxacin, ceftri-
axone, doxacillin, and gentamicin.
The community dispensary (location C), included seven
patients with complaints of headache (n = 2), fever (n = 2), and
rash, back pain, and anemia (n = 1 each), one visitor, and ﬁve staff
members. No patient reported current antibiotic use.
3.1. Statistical analysis
Among 143 participants responding to the question on current
antibiotic use, 38/127 (30%) who did not have S. aureus and 4/16
(25%) with S. aureus colonization reported current antibiotic use.
However, there was no signiﬁcant difference in the proportions
between the two groups (no S. aureus vs. S. aureus; p = 0.779,
Fisher’s exact test). Regarding past antibiotic use (at any point),
two of 143 participants did not answer. Among the 141 participantsresponding, 35/125 (28%) who did not have S. aureus and 5/16
(31%) with S. aureus reported past antibiotic use. There was no
signiﬁcant difference in the proportions between the two groups
(no S. aureus vs. S. aureus; p = 0.774, Fisher’s exact test). Overall, 67/
127 (53%) of those not colonized with S. aureus and 9/16 (56%) with
S. aureus colonization reported current or past antibiotic use. There
was no signiﬁcant difference in the proportions between the two
groups (no S. aureus vs. S. aureus; p = 1.000, Chi-square test). In
aggregate, there was no signiﬁcant association between S. aureus
and antibiotic use, either past antibiotic use, current antibiotic use,
or any (past or current) antibiotic use.
Due to the high percentage of tetracycline resistance, we
evaluated past doxycycline use by self-report and current
doxycycline use, from both self-report and current antibiotic
administration records when available. There were ﬁve partici-
pants who did not have S. aureus and reported doxycycline use
(four past and one current) (4%, 5/127); compared to the two
participants who had S. aureus and reported past doxycycline use
(13%, 2/16), there was no signiﬁcant difference in the proportions
(p = 0.177, Fisher’s exact test). To summarize, no association was
found between doxycycline use and S. aureus.
3.2. Microbiological results
All of the swabs taken from the 143 individuals sampled yielded
a polymicrobial nasal ﬂora, with 16/143 (11.2%) positive for S.
aureus. Twelve of these S. aureus were MSSA (75%) and only four
(25%) were MRSA using the automated susceptibility panels
(VITEK2). The overall carriage rate of MSSA was 8.4% and of MRSA
was 2.8% in our screened population (Table 2).
Table 3
Minimum inhibitory concentrations (MICs), susceptibility proﬁles, and summary antibiogram
Cefoxitin screen OXA GEN CIP ERY CLIa Q–D LZD VAN TET TGC DAPb
1 Neg 0.5 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) >16 (R) <0.12 (S) 0.75
2 Neg <0.25 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) >16 (R) <0.12 (S) 2
3 Neg <0.25 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) <1 (S) <0.12 (S) 1
4 Neg <0.5 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) <1 (S) <0.12 (S) 1
5 Neg 2.0 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) 0.5 (S) 4 (S) 1 (S) >16 (R) 0.25 (S) 0.5
6 Neg <0.5 (S) <0.5 (S) <0.5 (S) >8 (R) <0.25b (R) <0.25 (S) 2 (S) 1 (S) >16 (R) <0.12 (S) 0.75
7 Pos >4.0 (R) <0.5 (S) =2.0 (I) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) >16 (R) 0.25 (S) 1.5
8 Pos >4.0 (R) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) <1 (S) <0.12 (S) 1
9 Neg 0.5 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 0.5 (S) >16 (R) <0.12 (S) 0.75
10 Pos >4.0 (R) <0.5 (S) <0.5 (S) >8 (R) <0.25b (R) <0.25 (S) 2 (S) 1 (S) >16 (R) 0.25 (S) 1.5
11 Neg 0.5 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) <1 (S) <0.12 (S) 0.5
12 Neg 0.5 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) >16 (R) <0.12 (S) 1
13 Pos >4.0 (R) >16 (R) >8 (R) >8 (R) >8 (R) <0.25 (S) 2 (S) 1 (S) <1 (S) <0.12 (S) 0.75
14 Neg 0.25 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) >16 (R) <0.12 (S) 1
15 Neg 2.0 (S) <0.5 (S) <0.5 (S) >8 (R) <0.25b (R) <0.25 (S) >8 (R) 1 (S) >16 (R) 0.25 (S) 1.5
16 Neg 0.5 (S) <0.5 (S) <0.5 (S) <0.25 (S) <0.25 (S) <0.25 (S) 2 (S) 1 (S) <1 (S) <0.12 (S) 1.5
Summary antibiogram
GEN CIP ERY CLId Q–D LZD VAN TET TGC DAPb
MSSA n = 12
(75%)
11/12 (91.7%) 12/12
(100%)
10/12
(83.3%)
10/12
(83.3%)
12/12
(100%)
11/12
(91.7%)
12/12
(100%)
4/12
(33.3%)
12/12
(100%)
9/12
(75%)
MRSA n = 4
(25%)
1/4
(25%)
2/4c
(50%)
2/4
(50%)
2/4
(50%)
4/4
(100%)
4/4
(100%)
4/4
(100%)
2/4
(50%)
4/4
(100%)
2/4
(50%)
OXA, oxacillin; GEN, gentamicin; CIP, ciproﬂoxacin; ERY, erythromycin; CLI, clindamycin; Q–D, quinupristin–dalfopristin; LZD, linezolid; VAN, vancomycin; TET, tetracycline;
TGC, tigecycline; DAP, daptomycin; (S), susceptible; (I), intermediate; (R), resistant; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus.
a MIC and D test.
b Etest results (all others are automated VITEK2 results).
c Includes ciproﬂoxacin intermediate.
d Includes the D test.
Table 4
Molecular epidemiology of Staphylococcus aureus isolates
spa type spa repeats Ridom CC/ST SCCmec PVL TSST
35 UJFKBPE t127 CC1 mssa +
2 TJMBMDMGMK t002 CC5 mssa
140 TJMBMMK t954 CC5 mssa +
154 YC2FMBQBLOO t701 CC8 mssa
154 YC2FMBQBLOO t701 CC8 mssa
1588 UJGBBGGJAAGJAGJ t13937 CC15 mssa
220 XKAKEMBKB t073 CC45 mssa
449 UJGFGDMGG T537 CC72 mssa
1590 UJGFGDMG T11108 CC72 mssa
1589 UJ2GMKPNSG t1299 ST152 mssa +
1589 UJ2GMKPNSG t1299 ST152 mssa +
2 TJMBMDMGMK t002 CC5 II
2 TJMBMDMGMK t002 CC5 IV
193 UJGFGMDMGGM t148 CC72 IV
193 UJGFGMDMGGM t148 CC72 IV
CC/ST, clonal complex/sequence type; PVL, Panton–Valentine leukocidin; TSST,
toxic shock syndrome toxin.
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MSSA and MRSA isolates were susceptible to rifampin (MIC < 0.5),
trimethoprim–sulfamethoxazole (MIC < 10), vancomycin, quinu-
pristin–dalfopristin, and tigecycline (individual MICs reported in
Table 3). Of the total S. aureus population, the majority (10/16,
62.5%) were resistant to tetracycline.
One MRSA isolate from an inpatient at location B demonstrated
resistance to gentamicin, ﬂuoroquinolones, erythromycin, and
clindamycin (constitutive resistance), and susceptibility to tri-
methoprim–sulfamethoxazole, rifampin, tetracycline, vancomy-
cin, linezolid, and daptomycin.
Daptomycin non-susceptibility, deﬁned as a MIC 1.5, was
present in ﬁve S. aureus isolates – three MSSA and two MRSA – all
unrelated to vancomycin susceptibility. Interestingly, we identi-
ﬁed a single MSSA isolate that demonstrated intrinsic linezolid
resistance (Table 3).
3.3. Molecular epidemiology
Testing of duplicate colonies revealed conﬁrmation of DNA
sequence and toxin gene analysis in all cases, except for one isolate
in which typing failed for one of three duplicate colonies and one
MSSA which failed spa typing on all duplicate attempts. No
multiple lineage staphylococcal carriage was identiﬁed. Although a
comparatively small number of S. aureus was present, we found a
fair amount of genotypic diversity represented among the strains,
with a lack of a predominant colonizing strain (Table 4). The most
prevalent S. aureus strains belonged to CC72 (n = 4) and CC5 (n = 4).
CC8 and ST152 represented an additional two MSSA isolates each.
This ST152 ‘aberrant strain’, classiﬁed as ‘genetically divergent’, is
unassigned to a CC, and although this strain has previously been
reported to have acquired SCCmec and to have disseminated from
Africa through Europe, we did not identify ST152 MRSA isolates in
Haiti.16–18
Interestingly, both MSSA ST152 isolates were PVL-positive and
identiﬁed in patients, one with an 8-day hospitalization at locationA and the other with an 11-month hospitalization for a spinal cord
injury at location B. One additional PVL-positive CC1 (t127,
UJFKBPE) MSSA was identiﬁed. One CC5 strain carried TSST. ACME
was not detected in any S. aureus isolate.
Of the four MRSA, three strains were isolated from staff at
location A and one from a patient with a 5-month stay at location B,
the long-term rehabilitation facility, after a 4-month hospitaliza-
tion in Port-au-Prince. Two MRSA strains were spa type 193 (t148,
UJGFGMDMGGM, CC72) and two strains were spa type 2 (t002,
TJMBMDMGMK, CC5), one of which carried SCCmec type II and the
other type IV.
4. Discussion
To our knowledge, this is the ﬁrst survey of S. aureus
colonization in northern Haiti. A comparatively low overall S.
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identiﬁed. This was coupled with a low rate of health-care worker
nasal colonization, with three nursing/operating room staff
positive for MRSA nasal colonization. Not surprisingly, the single
patient with MRSA nasal colonization was noted to be a long-term
care facility patient, with a total hospital stay of nearly 9 months.
A second important clinically relevant conclusion to be drawn
from this cohort is the inherent tetracycline resistance noted in this
population. The mainstay for outpatient treatment of MRSA in the
USA includes doxycycline, and given the high rate of tetracycline
resistance in MSSA (8/12, 66.7%) and MRSA (2/4, 50%), doxycycline/
tetracycline may have limited utility as anti-staphylococcal agents
in northern Haiti. As an alternative, however, it may be useful to
evaluate minocycline availability, as the mechanism of resistance
conferring tetracycline and doxycycline resistance via tetK does
not affect minocycline susceptibility.19 We reported susceptibility
to ciproﬂoxacin (Table 3) and tested levoﬂoxacin and moxiﬂoxacin,
which demonstrated similar susceptibility patterns (data avail-
able), although treatment guidelines recommend against mono-
therapy with quinolones if S. aureus is of clinical concern.7
Also of note, we identiﬁed colonization strains of vancomycin-
susceptible MSSA and MRSA with unique resistance phenotypes;
one MSSA strain demonstrated linezolid resistance, while ﬁve
daptomycin non-susceptible S. aureus strains were noted, possibly
mediated by mutations in phospholipid biosynthesis genes.20 The
mechanism of resistance for these isolates deserves further
evaluation.
Molecular analysis revealed that USA300, the initially epidemic
but now endemic US strain of community-associated MRSA
(CA-MRSA), was visibly absent from our cohort, as were CC22 and
CC30 (EMRSA-15 and EMRSA-16, respectively), which predom-
inate in Europe.21 The four MRSA isolates, two from CC5 (t002,
TJMBMDMGMK), a common, widespread circulating clone, and two
from CC72 (t148, UJGFGMDMGGM), an uncommon, sparsely
reported clone, may represent potential founder strains in this
location. These clones may have evolved from the more prevalent
MSSA strains, which then acquired the SCCmec resistance determi-
nant, imparting methicillin resistance. It is unclear as to whether,
with increased exposure to antibiotics and further contact with
international medical personnel, clonal expansion or strain replace-
ment with a more virulent MSSA or MRSA will occur.
Our virulence analysis demonstrated PVL to be restricted to
MSSA isolates, with 18.8% (n = 3) carrying the two-component
enterotoxin. Two PVL-positive patient isolates were noted in the
ST152 genetic background (see Table 4), and a third PVL-positive
CC1 MSSA was isolated from a nurse who reported no prior
antibiotic exposure. The high frequency of PVL positivity in MSSA,
and speciﬁcally in ST152, conﬁrms the recent reports of PVL-
positive MSSA ST152 circulating at a high frequency among
countries in Africa, including Ghana and Mali, and now Haiti.22,23
Although PVL has been associated with neutrophil destruction and
controversially associated with necrotizing skin and pulmonary
infections,24–27 this association was not noted in our population.
The genotypically diverse population structure with minimal
MRSA carriage is likely a factor of less antibiotic utilization, and
therefore selection pressure. This is supported by our statistical
analysis, which showed the use of past or current antibiotics not to
be statistically signiﬁcant, although this ﬁnding may be explained
by the small sample size. Unique resistance patterns, such as
unexpected linezolid and daptomycin resistance, deserve further
study, especially if these antimicrobials are made available to this
population. Increased surveillance over time may be beneﬁcial in
understanding the evolution of both MSSA and MRSA in this island
nation. A larger national longitudinal cohort study could potentially
answer this question, as well as track potential dissemination of the
previously geographically limited ST152 PVL-positive MSSA clone.This was a brief, time-limited surveillance study. Inherent bias
exists in a study with voluntary participation, although this was
mitigated by the overall high participation rate at the three
disparate locations, capturing a range of patients, visitors, and
health-care personnel.
We were unable to correlate colonization with infection due to
resource limitations, and are therefore limited in our ability to
draw conclusions based on probability of infection. It is reassuring,
however, that our overall nasal carriage rate was low, and we
would therefore expect a low MRSA infection rate. This is an
important ﬁnding that supports a narrower spectrum of antibiotic
coverage in Haiti, as opposed to the USA and Europe with high
endemic MRSA colonization and infection rates in the community
and hospitalized populations.
In conclusion, it is important to note the low endemic carriage
rate of both MSSA and MRSA in Haiti, likely due to limited
antibiotic availability and therefore less selection pressure
favoring resistant organisms. The surprising ﬁnding of the high
rate of tetracycline resistance in S. aureus warrants caution, and
may portend a tetracycline-resistant ‘Haiti MSSA or MRSA clone’
disseminating in this population. Furthermore, if clinical treatment
failure is encountered in patients on tetracycline, the clinician
should maintain a high suspicion of infection with a tetracycline-
resistant organism. Currently, however, based on this analysis, a
high rate of MSSA and MRSA wound infections following mass
casualty events, such as the devastating 2010 earthquake, is
expected to be highly unlikely given the low endemic carriage rate.
Resources permitting, further screening on a national level may
provide additional information as to the molecular microevolution
of S. aureus in this island nation and its dissemination. Further, this
may assist in the choice of empiric antibiotics and targeted
treatment, prevention, and containment strategies.
Funding sources: Internal.
Conﬂict of interest: None, as reported by all contributing authors.
References
1. Centers for Disease Control, Prevention (CDC). Post-earthquake injuries treated
at a ﬁeld hospital—Haiti, 2010. MMWR Morb Mortal Wkly Rep 2011;59:1673–7.
2. Jaffer AK, Campo RE, Gaski G, Reyes M, Gebhard R, Ginzburg E, et al. An academic
center’s delivery of care after the Haitian earthquake. Ann Intern Med
2010;153(4):262–5.
3. Bar-On E, Lebel E, Kreiss Y, Merin O, Benedict S, Gill A, et al. Orthopaedic manage-
ment in a mega mass casualty situation. The Israel Defence Forces Field Hospital in
Haiti following the January 2010 earthquake. Injury 2011;42(10):1053–9.
4. Hussey SM, Dukette PJ, Dunn SH, Evans TJ, Oakes NY, Gleeson TD, et al. The
2010 Haiti earthquake: a pathology perspective aboard the USNS Comfort.
Arch Pathol Lab Med 2011;135(4):417–21.
5. Gardiner BJ, Grayson ML, Wood GM. Inducible resistance to clindamycin in
Staphylococcus aureus: validation of Vitek-2 against CLSI D-test. Pathology
2013;45:181–4.
6. Kamboj S, Yousef E, McGeady S, Hossain J. The prevalence of antibiotic skin test
reactivity in a pediatric population. Allergy Asthma Proc 2011;32(2):99–105.
7. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical
practice guidelines by the Infectious Diseases Society of America for the
treatment of methicillin-resistant Staphylococcus aureus infections in adults
and children. Clin Infect Dis 2011;52(3):e18–55.
8. Noel F, Wright PF, Bois G, Deschamps MM, de Matteis P, Cassangnol R, et al.
Contribution of bacterial sepsis to morbidity in infants born to HIV-infected
Haitian mothers. J Acquir Immune Deﬁc Syndr 2006;43(3):313–9.
9. Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, et al.
New real-time PCR assay for rapid detection of methicillin-resistant Staphylo-
coccus aureus directly from specimens containing a mixture of staphylococci. J
Clin Microbiol 2004;42(5):1875–84.
10. Chen L, Mediavilla JR, Oliveira DC, Willey BM, de Lencastre H, Kreiswirth BN.
Multiplex real-time PCR for rapid staphylococcal cassette chromosome mec
typing. J Clin Microbiol 2009;47(11):3692–706.
11. Bowling JE, Owens AE, McElmeel ML, Fulcher LC, Herrera ML, Wickes BL, et al.
Detection of inducible clindamycin resistance in beta-hemolytic streptococci
by using the CLSI broth microdilution test and erythromycin–clindamycin
combinations. J Clin Microbiol 2010;48(6):2275–7.
12. Woods CR. Macrolide-inducible resistance to clindamycin and the D-test.
Pediatr Infect Dis J 2009;28:1115–8.
M.E. Rosenthal et al. / International Journal of Infectious Diseases 29 (2014) 146–151 15113. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE,
et al. Evaluation of protein A gene polymorphic region DNA sequencing for
typing of Staphylococcus aureus strains. J Clin Microbiol 1999;37(11):3556–63.
14. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D, et al. Typing of
methicillin-resistant Staphylococcus aureus in a university hospital setting by
using novel software for spa repeat determination and database management. J
Clin Microbiol 2003;41(12):5442–8.
15. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion
method for detection of inducible clindamycin resistance in Staphylococcus aureus
and coagulase-negative staphylococci. J Clin Microbiol 2003;41(10):4740–4.
16. Okon KO, Basset P, Uba A, Lin J, Oyawoye B, Shittu AO, et al. Co-occurrence of
predominant Panton–Valentine leukocidin-positive sequence type (ST) 152
and multidrug-resistant ST 241 Staphylococcus aureus clones in Nigerian hos-
pitals. J Clin Microbiol 2009;47(9):3000–3.
17. Nubel U, Roumagnac P, Feldkamp M, Song JH, Ko KS, Huang YC, et al. Frequent
emergence and limited geographic dispersal of methicillin-resistant Staphylo-
coccus aureus. Proc Natl Acad Sci U S A 2008;105(37):14130–5.
18. Monecke S, Slickers P, Ehricht R. Assignment of Staphylococcus aureus isolates to
clonal complexes based on microarray analysis and pattern recognition. FEMS
Immunol Med Microbiol 2008;53(2):237–51.
19. Schwartz BS, Graber CJ, Diep BA, Basuino L, Perdreau-Remington F, Chambers
HF. Doxycycline, not minocycline, induces its own resistance in multidrug-
resistant, community-associated methicillin-resistant Staphylococcus aureus
clone USA300. Clin Infect Dis 2009;48(10):1483–4.
20. Peleg AY, Miyakis S, Ward DV, Earl AM, Rubio A, Cameron DR, et al. Whole genome
characterization of the mechanisms of daptomycin resistance in clinical and
laboratory derived isolates of Staphylococcus aureus. PLoS One 2012;7(1):e28316.21. Knight GM, Budd EL, Whitney L, Thornley A, Al-Ghusein H, Planche T, et al.
Shift in dominant hospital-associated methicillin-resistant Staphylococcus
aureus (HA-MRSA) clones over time. J Antimicrob Chemother 2012;67(10):
2514–22.
22. Egyir B, Guardabassi L, Sorum M, Nielsen SS, Kolekang A, Frimpong E, et al.
Molecular epidemiology and antimicrobial susceptibility of clinical Staphylo-
coccus aureus from healthcare institutions in Ghana. PLoS One 2014;9(2):
e89716.
23. Ruimy R, Maiga A, Armand-Lefevre L, Maiga I, Diallo A, Koumare AK, et al. The
carriage population of Staphylococcus aureus from Mali is composed of a
combination of pandemic clones and the divergent Panton–Valentine leuko-
cidin-positive genotype ST152. J Bacteriol 2008;190(11):3962–8.
24. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al.
Involvement of Panton–Valentine leukocidin-producing Staphylococcus au-
reus in primary skin infections and pneumonia. Clin Infect Dis 1999;29(5):
1128–32.
25. Bae IG, Tonthat GT, Stryjewski ME, Rude TH, Reilly LF, Barriere SL, et al. Presence
of genes encoding the Panton–Valentine leukocidin exotoxin is not the primary
determinant of outcome in patients with complicated skin and skin structure
infections due to methicillin-resistant Staphylococcus aureus: results of a mul-
tinational trial. J Clin Microbiol 2009;47(12):3952–7.
26. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR.
Panton–Valentine leukocidin is not a virulence determinant in murine models
of community-associated methicillin-resistant Staphylococcus aureus disease. J
Infect Dis 2008;198(8):1166–70.
27. Diep BA, Otto M. The role of virulence determinants in community-associated
MRSA pathogenesis. Trends Microbiol 2008;16(8):361–9.
